Matthew Stanton
Stock Analyst at Jefferies
(0.11)
# 4,485
Out of 5,134 analysts
8
Total ratings
20%
Success rate
-23.18%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AZTA Azenta | Maintains: Buy | $42 → $40 | $28.64 | +39.66% | 3 | Feb 4, 2026 | |
| RGEN Repligen | Maintains: Hold | $145 → $135 | $135.41 | -0.30% | 1 | Sep 12, 2025 | |
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $8.47 | -5.55% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.12 | +190.18% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $22.36 | -1.61% | 1 | Apr 4, 2024 |
Azenta
Feb 4, 2026
Maintains: Buy
Price Target: $42 → $40
Current: $28.64
Upside: +39.66%
Repligen
Sep 12, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $135.41
Upside: -0.30%
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $8.47
Upside: -5.55%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.12
Upside: +190.18%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $22.36
Upside: -1.61%